30 Day Trial

Smith & Nephew's eCAP Adopted by Provider PPI


Smith & Nephew (SNN) announced that Provider PPI, a U.S. health and wellness organization, has adopted its Episode of Care Assurance Program (eCAP), an initiative designed to mitigate risk associated with readmissions in value-based healthcare reimbursement models. Provider PPI is a subsidiary of Highmark Health that provides group purchasing benefits to ~60 hospitals and healthcare providers in the western Pennsylvania region.

eCAP pairs all SNN primary total hip and knee reconstructive systems with PICO™ Single Use Negative Pressure Wound Therapy and ACTICOAT™ Flex 7 Silver-coated Antimicrobial Barrier Dressing. SNN warrants the performance of its primary total knee systems, primary total hip systems, PICO Single Use Negative Pressure Wound Therapy System and ACTICOAT Flex 7 to perform as expected. If a patient is readmitted within 90 days following a procedure for a surgical site infection or for implant revision due to product failure, SNN will pay a hospital's unreimbursed costs for the readmission up to the purchase prices of the implant, PICO and ACTICOAT Flex 7.

SNN announced the addition of its warranty/combination program to its Syncera model earlier this year. When used post-op, SNN essentially guarantees against a surgical site infection over the 90-day episode. 

Sources: Smith & Nephew plc; ORTHOWORLD Inc.

Throughout 2016, numerous products, services and partnerships have emerged to assist in delivery of care; for example: